We confirmed this conclusion through the analysis of mutational frequencies in LGG and GBM (IDH1, 77% vs 7%; PTEN, 5% vs 29%; EGFR, 5% vs 17%; Supplementary Figs. 1 and 2). This evidence concerns the gene PTEN and glioblastoma.